Vanguard Group Inc Oragenics Inc Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.11 - $15.59 $221 - $31,367	2,012 Added 0.04%	5,063,135 $556,000
Q1 2022 May 13, 2022	SELL	$0.33 - $0.56 $7,932 - $13,461	-24,038 Reduced 0.47%	5,061,123 $1.74 Million
Q4 2021 Feb 14, 2022	BUY	$0.43 - $0.69 $14,100 - $22,627	32,793 Added 0.65%	5,085,161 $2.27 Million
Q3 2021 Nov 12, 2021	BUY	$0.58 - $0.84 $12,132 - $17,571	20,918 Added 0.42%	5,052,368 $3.21 Million
Q2 2021 Aug 13, 2021	BUY	$0.6 - $0.89 $3.02 Million - $4.48 Million	5,031,450 New	5,031,450 $3.55 Million

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $36.1M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.